Catalyst Wire Dossier Catalyst Wire Dossier

Buprenorphine 8 mg sublingual tablets

buprenorphine · Teva Pharmaceuticals USA
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Buprenorphine 8 mg sublingual tablets, covering 2010-09-13 to 2010-09-13. Get the full timeline:

Most recent: Clinical Trial Update: Buprenorphine 8 mg Sublingual Tablets Under Fasting Conditions [Phase 1]

See pricing